Jim Cramer's top 10 things to watch in the stock market Thursday

Stocks are modestly higher, but sentiment is volatile as Trump’s Iran attack comments pushed oil prices higher and added geopolitical risk. The article highlights multiple AI and semiconductor catalysts, including Intel’s double upgrade to buy, raised targets for AMD, Arm, Lam Research, KLA, and Applied Materials, plus strong demand for SpaceX and Super Micro financing. Offseting that, Oracle is weaker after earnings and another $20 billion capital raise, while wholesale inflation in May came in above expectations.

Analysis

The tape is being pulled by two opposing forces: a near-term inflation/geopolitics shock and a medium-term capex boom that is increasingly self-financed through equity and equity-linked issuance. That combination is bullish for the “picks and shovels” in semis and optics, but it is a tax on the underlying AI infrastructure builders, where financing costs and dilution can start to outrun the narrative. The market is still rewarding order books, yet the next leg depends on cash conversion, not bookings; that’s why the higher-beta winners are likely the suppliers with pricing power rather than the serial fundraisers.

INTC is the cleanest asymmetry in the list: improved foundry credibility plus exposure to agentic CPU demand creates a rerating path if execution inflects even modestly over the next 2-3 quarters. By contrast, ORCL looks like the most fragile “AI beneficiary” because it is shifting from software-margin economics toward balance-sheet-intensive infrastructure, which compresses the multiple even if revenue visibility remains high. SMCI sits in the middle: backlog supports the stock, but repeated capital raises can cap upside unless delivery and gross margin expansion arrive faster than dilution.

COHR/LITE/NVDA/GLW are the better second-order ways to express the optical interconnect theme because the supply chain still looks tighter than demand, meaning incremental upside should accrue to vendors with leverage over timing and specs. LRCX/AMAT benefit from the same capex wave, but their setup is more durable because pricing power tends to lag order momentum by multiple quarters; this is one of the few places where analysts are probably still underestimating margin resilience. On the contrarian side, the market may be too sanguine on how quickly AI capex turns into equity supply overhang, which can raise the cost of capital for the whole ecosystem even if end-demand remains intact.

Key Decisions for Investors

• Long INTC vs short ORCL for a 1-2 quarter relative-value trade: INTC has rerating potential on execution credibility, while ORCL is at risk of multiple compression from capex dilution and debt increase.
• Add COHR or GLW on 5-10% pullbacks, targeting a 2-3 month horizon: these names should capture the next leg of optics demand with less financing overhang than SMCI/NVDA-linked builders.
• Buy LRCX/AMAT on weakness as a 6-12 month compounder trade: supply scarcity supports pricing power, and the risk/reward improves if AI capex broadens beyond the current headline names.
• Keep SMCI as a tactical trade only, not a core hold: upside exists if order conversion stays frantic, but dilution risk makes it a poor risk-adjusted long until financing terms clear.
• Use any strength in ORCL to fade into earnings-driven relief: the stock can bounce on backlog rhetoric, but the next catalyst is balance-sheet scrutiny, not multiple expansion.